Stock Momentum Builds For Agenus (AGEN) On Heels Of Clinical Trial News
Agenus Inc. (NASDAQ: AGEN) has witnessed a notable upsurge in its stock position, marking a gain of 14.09% and reaching $7.37. This increase in AGEN stock value closely follows the disclosure of an imminent presentation concerning a significant clinical trial. Earlier today, Agenus (AGEN) unveiled plans to present findings from a Phase 1b investigation of […]
